151 related articles for article (PubMed ID: 17525897)
41. Review article: renal function assessment in cirrhosis - difficulties and alternative measurements.
Cholongitas E; Shusang V; Marelli L; Nair D; Thomas M; Patch D; Burns A; Sweny P; Burroughs AK
Aliment Pharmacol Ther; 2007 Oct; 26(7):969-78. PubMed ID: 17877504
[TBL] [Abstract][Full Text] [Related]
42. Tumor lysis under anesthesia in a child.
Sinha R; Bose S; Subramaniam R
Acta Anaesthesiol Scand; 2009 Jan; 53(1):131-3. PubMed ID: 19032562
[TBL] [Abstract][Full Text] [Related]
43. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study.
Ioachimescu AG; Brennan DM; Hoar BM; Hazen SL; Hoogwerf BJ
Arthritis Rheum; 2008 Feb; 58(2):623-30. PubMed ID: 18240236
[TBL] [Abstract][Full Text] [Related]
44. Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout.
Dalbeth N; Merriman T
Rheumatology (Oxford); 2009 Mar; 48(3):222-6. PubMed ID: 19109320
[TBL] [Abstract][Full Text] [Related]
45. Assessment of renal function in elderly patients.
Fliser D
Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):604-8. PubMed ID: 18941354
[TBL] [Abstract][Full Text] [Related]
46. Gout--what are the treatment options?
Schlesinger N; Dalbeth N; Perez-Ruiz F
Expert Opin Pharmacother; 2009 Jun; 10(8):1319-28. PubMed ID: 19463070
[TBL] [Abstract][Full Text] [Related]
47. Tumor lysis syndrome and neuroblastoma.
Milano GM; De Sio L; Cozza R; Donfrancesco A
Med Pediatr Oncol; 2003 Dec; 41(6):592. PubMed ID: 14595729
[No Abstract] [Full Text] [Related]
48. Oncological emergencies: tumor lysis syndrome.
Sobota J; Püsküllüoglu M; Zygulska AL
Przegl Lek; 2014; 71(4):210-4. PubMed ID: 25141580
[TBL] [Abstract][Full Text] [Related]
49. A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome.
Shimada M; Johnson RJ; May WS; Lingegowda V; Sood P; Nakagawa T; Van QC; Dass B; Ejaz AA
Nephrol Dial Transplant; 2009 Oct; 24(10):2960-4. PubMed ID: 19581334
[No Abstract] [Full Text] [Related]
50. Uric acid nephropathy as a presenting sign of chronic lymphocytic leukemia.
Hochman I; Peer G; Grosskopf I; Goor Y; Cabili S
Clin Nephrol; 1995 Jan; 43(1):64. PubMed ID: 7697938
[No Abstract] [Full Text] [Related]
51. Tumor lysis syndrome: prevention and detection to enhance patient safety.
Maloney K; Denno M
Clin J Oncol Nurs; 2011 Dec; 15(6):601-3. PubMed ID: 22119971
[TBL] [Abstract][Full Text] [Related]
52. Imatinib-induced tumor lysis syndrome: report of a case and review of the literature.
Chang H; Shih LY
Chang Gung Med J; 2008; 31(5):510-4. PubMed ID: 19097599
[TBL] [Abstract][Full Text] [Related]
53. Acute renal problems in the critically ill cancer patient.
Lameire N; Van Biesen W; Vanholder R
Curr Opin Crit Care; 2008 Dec; 14(6):635-46. PubMed ID: 19005304
[TBL] [Abstract][Full Text] [Related]
54. Is serum cystatin-C a reliable marker for metabolic syndrome?
Servais A; Giral P; Bernard M; Bruckert E; Deray G; Isnard Bagnis C
Am J Med; 2008 May; 121(5):426-32. PubMed ID: 18456039
[TBL] [Abstract][Full Text] [Related]
55. Impaired renal function in acute myocardial infarction.
Lekston A; Kurek A; Tynior B
Cardiol J; 2009; 16(5):400-6. PubMed ID: 19753517
[TBL] [Abstract][Full Text] [Related]
56. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
[TBL] [Abstract][Full Text] [Related]
57. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
[TBL] [Abstract][Full Text] [Related]
58. The role of hypercytokinemia in the pathophysiology of tumor lysis syndrome (TLS) and the treatment with continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA-CHDF).
Nakamura M; Oda S; Sadahiro T; Hirayama Y; Tateishi Y; Abe R; Hirasawa H
Transfus Apher Sci; 2009 Feb; 40(1):41-7. PubMed ID: 19109071
[TBL] [Abstract][Full Text] [Related]
59. Control of renal uric acid excretion and gout.
Taniguchi A; Kamatani N
Curr Opin Rheumatol; 2008 Mar; 20(2):192-7. PubMed ID: 18349750
[TBL] [Abstract][Full Text] [Related]
60. Tumor lysis syndrome: current perspective.
Hochberg J; Cairo MS
Haematologica; 2008 Jan; 93(1):9-13. PubMed ID: 18166779
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
